[A CASE OF RENAL CELL CARCINOMA WITH INFERIOR VENA CAVAL TUMOR THROMBUS WHICH THE REDUCTION OF TUMOR IN SPITE OF DRUG DISCONTINUANCE AFTER THE FULMINANT HEPATITIS ONSET WITH THE SUNITNIB]

Nihon Hinyokika Gakkai Zasshi. 2018;109(2):102-105. doi: 10.5980/jpnjurol.109.102.
[Article in Japanese]

Abstract

A 70-year-old man presented with right renal cell carcinoma with inferior vena caval tumor thrombus into the right atrium. CT Scan presented local invasion and lymph node metastasis. We estimated inoperative case, so he was started sunitinib. After 5 month he had general fatigue and admitted to our hospital. He diagnosed serious adverse events of fulminant hepatitis and left ventricular systolic dysfunction and discontinued sunitnib. After drug discontinuance reduction of tumor and tumor thrombus were detected. 7-months later, we showed the increase of tumor and the improvement of the left ventricular systolic dysfunction. We performed right renal nephrectomy and it passes now in 14 months after surgery, but doses not show a recurrence, metastasis.

Keywords: Sunitinib; fulminant hepatitis; inferior vena caval tumor thrombus.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Agents / adverse effects*
  • Carcinoma, Renal Cell / complications
  • Carcinoma, Renal Cell / diagnostic imaging
  • Carcinoma, Renal Cell / pathology
  • Carcinoma, Renal Cell / therapy*
  • Chemical and Drug Induced Liver Injury / etiology*
  • Humans
  • Kidney Neoplasms / complications
  • Kidney Neoplasms / diagnostic imaging
  • Kidney Neoplasms / pathology
  • Kidney Neoplasms / therapy*
  • Lymphatic Metastasis
  • Male
  • Neoplasm Invasiveness
  • Nephrectomy
  • Risk
  • Sunitinib / adverse effects*
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Vena Cava, Inferior / diagnostic imaging*
  • Venous Thrombosis / diagnostic imaging*
  • Venous Thrombosis / etiology*
  • Withholding Treatment

Substances

  • Antineoplastic Agents
  • Sunitinib